Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01523496 · ClinicalTrials.gov registry record · Phase 2
Vitamin D Supplementation in HIV Youth
A Phase 2 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 190
- Enrollment target
NCT01523496 is a Phase 2 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 190 participants.
The verdict
NCT01523496, a Phase 2 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 190 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the correct dose of Vitamin D to give to prevent HIV related complications.
Interventions
- DRUG Vitamin D control dose
- DRUG Vitamin D supplementation-
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2011-12 |
| Est. Completion | 2016-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01523496
The ClinicalTrials.gov registry entry for NCT01523496 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D control dose is the first listed.
NCT01523496 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01523496 about?
NCT01523496 is a clinical study titled "Vitamin D Supplementation in HIV Youth". The purpose of this study is to determine the correct dose of Vitamin D to give to prevent HIV related complications.
What is the current status of trial NCT01523496?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 190 participants. The study started on 2011-12. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01523496?
The interventions under investigation include: Vitamin D control dose (DRUG), Vitamin D supplementation- (DRUG).
Who is sponsoring clinical trial NCT01523496?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.